Insider buying last 90 days
No open-market insider purchases were filed for ICUI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ICUI insider filing, plotted on the chart in Gekko.Open ICUI in Gekko
NASDAQ: ICUI
ICU Medical (ICUI) Stock Analysis & Forecast
Sep 28 close
$164.03−0.92 (−0.6%)
Gekko Brief
AI summaryICU Medical draws analyst attention this week, with Argus raising its target price to $169.00 from a prior $166.02, and J.P. Morgan among firms offering views alongside RBC's coverage of peers Hexcel and International Paper. Separately, Otsuka ICU Medical issued a recall of one lot of IV saline after a potassium chloride bag was found inside a saline overwrap, with no adverse events reported. A comparison piece also weighed ICUI against Ambu A/S on earnings, risk and valuation grounds.
Shares closed at $164.03, down 0.6%, sitting between the 50-day average of $168.66 and the 200-day average of $146.78. The GekkoIndex reads 57, placing the stock in the Neutral zone, down from a five-day change of -13.7. Price sits 8.1% below Gekko Fair Value of $178.55.
The next earnings report is set for 5 November, 37 days out, after the prior quarter's beat of $2.01 versus a $1.49 estimate produced a 10.9% reaction. No insider, Congress or unusual options activity appears in the current windows, though one trailblazer holder is noted. Seasonality is a headwind, with the next 20 trading days averaging -4.1% over 4 years, positive in only 1 of them. Consensus among 5 firms remains all-buy, with a $193.38 target implying 17.9% upside.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
ICU Medical price vs fair value
Close $164.03200-day averageGekko Fair Value $178.55
ICU Medical quick facts
- Market cap
- $4.10B
- P/E ratio
- 138.6
- Forward P/E
- 17
- EPS, TTM
- $1.19
- Revenue, TTM
- $2.16B
- Profit margin
- 1.4%
- Dividend yield
- —
- Beta
- 0.76
- Volume
- 290,622 avg 259,553
- 1-year return
- +38.7%
- Typical daily move
- ±2.9%
- Typical 20-day move
- ±7%
- 50-day average
- $168.66
- 200-day average
- $146.78
- Next earnings
- Nov 5 after close
- Shares outstanding
- 25.01M
ICU Medical swing-trade checklist
ICU Medical scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $164.03 sits between the 50-day ($168.66) and 200-day ($146.78) averages, or the averages disagree.
See the chart - GekkoIndexmixed
57, Neutral
Reading 57 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
8.1% below
Price is 8.1% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 37 days
Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−4.1% on average
From this point in the calendar, the next 20 trading days averaged −4.1% over 4 years, rising in 1 of them.
See seasonality
A description of current data, not a recommendation. How this page works
ICU Medical stock chart and price history
ICU Medical closed at $164.03 on Sep 28, 2026, +38.7% over the past year, inside a 52-week range of $112.50 to $192.85.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −6.3%
- 3 months
- +10.9%
- 6 months
- +32.1%
- 1 year
- +38.7%
The full ICUI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ICUI in Gekko
Follow ICU Medical through every session
Put ICUI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ICUI in GekkoFree for 7 days. No credit card required.
About ICU Medical
ICU Medical designs, manufactures and sells medical devices used in infusion therapy and critical care, working through subsidiaries around the world. Its offerings span needlefree connectors, catheter maintenance and disinfection tools, hemodialysis accessories, and systems for safely handling hazardous drugs during compounding. The company is also known for its intravenous fluids and irrigation solutions, its infusion pumps such as Plum 360 and LifeCare PCA, and software that links smart pumps to hospital records, asset tracking and alarm systems.
Beyond infusion products, ICU Medical supplies equipment for critical care settings, including hemodynamic monitoring systems, cardiac output and oximetry catheters, blood pressure transducers, and closed blood sampling systems. Alongside its devices, it offers related professional services. Its customers include acute care hospitals, wholesalers, ambulatory clinics, and other alternate-site providers such as outpatient centers, home healthcare services and long-term care facilities.
The company was established in 1984 and is headquartered in San Clemente, California. Its shares are listed on the NASDAQ under the ticker ICUI.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- icumed.com
ICU Medical GekkoIndex: the smart money zone
ICU Medical’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57, in the Neutral zone, down 13.7 points over five sessions.
57Neutral
Down 13.7 points over five sessions, from the Buying zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 20 | +4.2% | +7.9% | ||
| Accumulation | 158 | +0.9% | +1.8% | ||
| Neutral (current zone) | 331 | +0.4% | +2.8% | ||
| Distribution | 37 | −0.2% | +2.4% | ||
| Selling | 1 | Too few readings yet | |||
Average ICUI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the ICUI price, zone by zone.Track ICUI in Gekko
Is ICU Medical stock overvalued? Gekko Fair Value
ICU Medical trades 8.1% below Gekko Fair Value of $178.55, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what ICU Medical shares are worth, recalculated every trading day.
$178.55
Gekko Fair Value, Sep 29, 2026
8.1% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open ICUI in Gekko
ICU Medical insider and Congress trading
No open-market insider purchases were filed for ICU Medical, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ICUI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ICUI, plotted on the chart in Gekko.Open ICUI in Gekko
Buybacks
ICU Medical has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $38.78M
- As a share of market cap
- 0.95%
- Trailing four quarters
- $86.35M
From company filings.
Hedge funds and billionaires quarter ended Mar 31
1of the funds Gekko tracks holds ICUI.
0added0opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
ICU Medical earnings: next date and track record
ICU Medical reports on Nov 5, 2026, after the close (37 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected after the close, 37 days away
- EPS estimate
- $2.14
- Revenue estimate
- $552.1M
8 of 8reports beat the EPS estimate
±9.3%average move across the report
6 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 6, 2026 AI summary
- What they said
- ICU Medical reported Q2 2026 revenue of $548 million, with 6% organic growth and 1% reported growth (impacted by Otsuka ICU Medical JV deconsolidation). Adjusted gross margins reached 41%, adjusted EBITDA was $110 million, and adjusted EPS was $2.37. The company repaid $50 million in debt and targets approximately 2x leverage by year-end. IV Systems grew 12% organically, Consumables grew 5% organically hitting a record, while Vital Care declined 4% organically.
- Guidance
- Management expects Consumables to achieve mid-single-digit growth for the remainder of 2026. IV Systems organic growth is expected to continue at or above 6% in Q3. Vital Care expected to show stability but finish slightly down for the full year due to weak Q1 results.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $2.01 est $1.49 | $547.9M est $533.4M | +10.9% |
| May 7, 2026 | $1.97 est $1.75 | $525.8M est $520.6M | +5.7% |
| Feb 19, 2026 | $1.91 est $1.69 | $535.9M est $530.6M | +3.6% |
| Nov 6, 2025 | $2.03 est $1.43 | $537.0M est $511.5M | +10.0% |
| Aug 7, 2025 | $2.10 est $1.44 | $548.9M est $511.5M | −11.1% |
| May 8, 2025 | $1.72 est $1.28 | $604.7M est $603.7M | +2.8% |
| Feb 27, 2025 | $2.11 est $1.48 | $629.8M est $599.1M | −5.1% |
| Nov 12, 2024 | $1.59 est $1.25 | $589.1M est $574.6M | +25.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
ICU Medical stock forecast and analyst price targets
Analysts’ average 12-month price target for ICU Medical is $193.38, +17.9% from the last close, from 5 firms rating the stock in the last 90 days.
$193.38consensus 12-month target, +17.9% from the last close
Now $164.03Avg $193.38
Low $175High $200
Each firm’s latest rating in the last 90 days: 5 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 23 | Piper Sandler | $195 | +18.9% |
| Sep 18 | Piper Sandler | $195 | +18.9% |
| Aug 7 | Piper Sandler | $195 | +18.9% |
| Aug 7 | Needham | $187 | +14.0% |
| Aug 7 | Raymond James | $200 | +21.9% |
+2.8%average 20-day move after past Neutral readings
−4.1%average move over the next 20 trading days in the last 4 years
±2.9%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
ICU Medical seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, ICU Medical averaged −4.1% across the last 4 years, rising in 1 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 3 of 4 |
| Next 10 trading days | −4.2% | 0 of 4 |
| Next 15 trading days | −4.2% | 1 of 4 |
| Next 20 trading days | −4.1% | 1 of 4 |
| Next 30 trading days | −1.8% | 3 of 4 |
For scale, ICUI’s typical 20-trading-day move in either direction is about 7%.
ICU Medical market cap and key statistics
ICU Medical’s market cap is $4.10B, with a P/E ratio of 138.6 and revenue of $2.16B over the last twelve months.
Valuation
- Market cap
- $4.10B
- P/E ratio
- 138.6
- Forward P/E
- 17
- EPS, TTM
- $1.19
- Gekko Fair Value
- $178.55
Trading
- Volume
- 290,622
- Avg volume, 20 days
- 259,553
- 52-week high
- $192.85
- 52-week low
- $112.50
- Shares outstanding
- 25.01M
Financials
- Revenue, TTM
- $2.16B
- Profit margin
- 1.4%
- Return on equity
- 1.4%
- Quarterly earnings growth, YoY
- −46.9%
Risk and income
- Beta
- 0.76
- Typical daily move
- ±2.9%
- Typical 20-day move
- ±7%
ICU Medical stock news this week
Coverage of ICU Medical this week reads negative: 1 positive, 1 neutral and 2 negative headlines.
- Analysts Offer Insights on NA Companies: Hexcel (HXL), International Paper Co (IP) and ICU Medical (ICUI)The Globe and Mail, Sep 25
- ICU Medical, Inc. (ICUI) Stock forecastsYahoo Finance Singapore, Sep 24
- A Look at ICU Medical Inc (ICUI) After 3.7% Gain -- GF Value $121.40 vs Price $160.98GuruFocus, Sep 22
- Otsuka ICU Medical Recalls One Lot of IV Saline After Potassium Chloride Bag Found Inside Saline OverwrapMedical Daily, Sep 21
- Reviewing ICU Medical (NASDAQ:ICUI) & Ambu A/S (OTCMKTS:AMBBY)Defense World, Sep 21
ICU Medical peers
ICU Medical’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
ICU Medical stock FAQ
What is ICU Medical’s market cap?
ICU Medical’s market cap is $4.10B at the Sep 28, 2026 close of $164.03, with 25.01M shares outstanding. The shares trade on a P/E ratio of 138.6.
What is the ICU Medical stock forecast?
The consensus analyst 12-month price target for ICU Medical is $193.38, +17.9% from the last close. Of the 5 firms that rated the stock in the last 90 days, 5 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is ICU Medical stock overvalued or undervalued?
On Gekko’s estimate ICU Medical is undervalued: the Sep 28, 2026 close of $164.03 is 8.1% below Gekko Fair Value of $178.55. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does ICU Medical report earnings next?
ICU Medical is expected to report on Nov 5, 2026, after the market closes (37 days away). Analysts expect earnings of $2.14 per share on revenue of $552.1M. ICU Medical beat the earnings estimate in 8 of its last 8 reports, moving 9.3% on average across the report.
What is ICU Medical’s 52-week high and low?
ICU Medical’s 52-week high is $192.85 and its 52-week low is $112.50; it closed at $164.03 on Sep 28, 2026, +38.7% over the past year. Over the last five years the shares peaked at $251.77 on Nov 19, 2021.
Is ICU Medical stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See ICU Medical the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.